Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Adjuvant Chemotherapy for HR+/HER2- Breast Cancer - How MINDACT, TAILORx and Prosigna Trials Affect Practice?
Login to view comments.
Click here to Login
Updates in Oncology